
Profitability, historical returns, and peer comparisons.
According to TNF Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -77.19%. This represents a change of 284.91% compared to the average of -20.06% of the last 4 quarters.
The mean historical ROE of TNF Pharmaceuticals, Inc. over the last ten years is -48.80%. The current -77.19% ROE has changed 58.19% with respect to the historical average. Over the past ten years (40 quarters), TNFA's ROE was at its highest in in the March 2026 quarter at -5.25%. The ROE was at its lowest in in the June 2024 quarter at -2502.18%.
Average
-48.80%
Median
-78.44%
Minimum
-158.69%
Maximum
180.48%
Discovering the peaks and valleys of TNF Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 406.78%
Maximum Annual ROE = 180.48%
Minimum Annual Increase = -170.03%
Minimum Annual ROE = -158.69%
| Year | ROE | Change |
|---|---|---|
| 2025 | -53.45% | -66.32% |
| 2024 | -158.69% | 406.78% |
| 2023 | -31.31% | -69.72% |
| 2022 | -103.42% | -18.18% |
| 2021 | -126.40% | -170.03% |
The current ROE of TNF Pharmaceuticals, Inc. (TNFA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-81.15%
5-year avg
-94.66%
10-year avg
-48.80%
TNF Pharmaceuticals, Inc.’s ROE is greater than Channel Therapeutics Corporation (-218.94%), greater than CervoMed Inc. (-156.02%), greater than IMV Inc. (-495.17%), less than Apexigen, Inc. (48.27%), greater than Cyclacel Pharmaceuticals, Inc. (-31.60%), greater than COSCIENS Biopharma Inc. (-48.52%), greater than Tvardi Therapeutics, Inc. (-145.40%), greater than Turnstone Biologics Corp. (-108.87%), greater than Omega Therapeutics, Inc. (-118.82%), less than Biora Therapeutics, Inc. (121.86%),
| Company | ROE | Market cap |
|---|---|---|
| -218.94% | $8.90M | |
| -156.02% | $24.64M | |
| -495.17% | $23.42K | |
| 48.27% | $9.57M | |
| -31.60% | $10.61M | |
| -48.52% | $8.57M | |
| -145.40% | $10.89M | |
| -108.87% | $8.21M | |
| -118.82% | $7.90M | |
| 121.86% | $994.99K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TNF Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TNF Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is TNF Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for TNF Pharmaceuticals, Inc. (TNFA)?
What is the highest ROE for TNF Pharmaceuticals, Inc. (TNFA)?
What is the 3-year average ROE for TNF Pharmaceuticals, Inc. (TNFA)?
What is the 5-year average ROE for TNF Pharmaceuticals, Inc. (TNFA)?
How does the current ROE for TNF Pharmaceuticals, Inc. (TNFA) compare to its historical average?